South America is the new coronavirus epicentre

Gravediggers wearing protective suits prepare to bury the coffin of a person who died from the coronavirus disease (Covid-19) during a ceremony with no relatives, at Vila Formosa cemetery, Brazil's biggest cemetery, in Sao Paulo, Brazil, May 22, 2020. REUTERS/Amanda Perobelli

Gravediggers wearing protective suits prepare to bury the coffin of a person who died from the coronavirus disease (Covid-19) during a ceremony with no relatives, at Vila Formosa cemetery, Brazil's biggest cemetery, in Sao Paulo, Brazil, May 22, 2020. REUTERS/Amanda Perobelli

Published May 23, 2020

Share

GENEVA - South America has become a new epicentre of the Covid-19 pandemic with Brazil hardest-hit, while cases are rising in some African countries that so far have a relatively low death toll, the World Health Organization (WHO) said.

“The Covid-19 pandemic today reached a milestone in Africa, with more than 100 000 confirmed cases. The virus has now spread to every country in the continent since the first case was confirmed in the region 14 weeks ago,” the WHO said in a statement, noting there were 3,100 confirmed deaths on the vast continent.

Dr. Matshidiso Moeti, WHO regional director for Africa, who is from Botswana, said: “For now Covid-19 has made a soft landfall in Africa, and the continent has been spared the high numbers of deaths which have devastated other regions of the world.”

Even so, she said, “We must not be lulled into complacency as our health systems are fragile and are less able to cope with a sudden increase in cases.”

About half of African countries are experiencing community transmission of the virus, the WHO said.

The situation in South America appeared graver. Dr. Mike Ryan, WHO’s top emergencies expert, speaking earlier to a news conference, said: “In a sense South America has become a new epicenter for the disease.”

Brazil is the “most affected,” and authorities there have approved broad use of the anti-malarial drug hydroxychloroquine for treatment of COVID-19, he said. He reiterated that clinical evidence does not support the drug’s widespread use against the disease, given its risks.

Nine African countries had 50% rises in cases in the past week, while others have seen a decline or have stable rates, Ryan said.

The low mortality rate may be because half the continent’s population is 18 or younger, he said, while saying he remains worried the disease will spread on a continent with “significant gaps” in intensive care services, medical oxygen and ventilation.

REUTERS

Related Topics: